The Effect of Smoking, Obesity and Diabetes on Recurrence-free and Overall Survival in Patients with Stage III Colon Cancer Receiving Adjuvant Chemotherapy

Overview

Journal Cancer Rep (Hoboken)

Specialty Oncology

Date 2021 Feb 8

PMID 33554476

Citations 3

Authors

Alex Croese

Richard Gartrell

Richard Hiscock

Margaret Lee

Peter Gibbs

Ian Faragher

Justin Yeung

Affiliations

Soon will be listed here.

Abstract

Background: The association between smoking, diabetes and obesity and oncological outcomes in patients with stage III colon cancer treated with surgery and adjuvant chemotherapy is unclear.

Aim: To evaluate whether smoking, obesity and diabetes are associated with the disease-free survival and overall survival rates of patients with stage III colon cancer who have received adjuvant chemotherapy.

Methods: Patients were selected from the prospectively maintained Australian Cancer Outcomes and Research Database (ACCORD). All stage III colon cancer patients who received adjuvant chemotherapy between January 2003 to December 2015 were retrospectively analyzed. The three primary exposures of interest were smoking status, body mass index (BMI) and diabetic (DM) status. The primary outcomes of interest were disease-free survival (DFS) and overall survival (OS).

Results: A total of 785 patients between 2003 and 2015 were included for analysis. Using Kaplan-Meier survivorship curves, there was no association between OS and smoking (P = .71), BMI (P = .3) or DM (P = .72). Similarly, DFS did not reveal an association with smoking (P = .34), BMI (P = .2) and DM (P = .34). Controlling for other covariates the results did not reach statistical significance in adjusted multiple regression models.

Conclusion: Smoking, obesity and DM were not shown to influence DFS or OS for patients with stage III colon cancer who have received adjuvant chemotherapy.

Citing Articles

Alcohol Consumption and Smoking History at the Time of Diagnosis and the Risk of Colorectal Cancer Recurrence and Mortality: Results from the ColoCare Study.

Lorona N, Himbert C, Ose J, Cohen S, Strehli I, Ulrich C Cancer Epidemiol Biomarkers Prev. 2024; 34(1):59-66.

PMID: 39373623 PMC: 11717602. DOI: 10.1158/1055-9965.EPI-24-0834.

Oral cavity and oropharyngeal carcinoma disparities in age and survival in Indigenous and non-Indigenous populations of Queensland.

Alkandari A, Ho J, Choi S, Thomson P BMC Cancer. 2023; 23(1):503.

PMID: 37270559 PMC: 10239569. DOI: 10.1186/s12885-023-11002-1.

WDR74 promotes proliferation and metastasis in colorectal cancer cells through regulating the Wnt/β-catenin signaling pathway.

Cai Z, Mei Y, Jiang X, Shi X Open Life Sci. 2021; 16(1):920-929.

PMID: 34553072 PMC: 8422980. DOI: 10.1515/biol-2021-0096.

The effect of smoking, obesity and diabetes on recurrence-free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy.

Croese A, Gartrell R, Hiscock R, Lee M, Gibbs P, Faragher I Cancer Rep (Hoboken). 2021; 4(3):e1346.

PMID: 33554476 PMC: 8222556. DOI: 10.1002/cnr2.1346.

References

Jayasekara H, English D, Haydon A, Hodge A, Lynch B, Rosty C . Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype. Int J Cancer. 2017; 142(2):238-250. DOI: 10.1002/ijc.31049. View

van de Poll-Franse L, Haak H, Coebergh J, Janssen-Heijnen M, Lemmens V . Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia. 2012; 55(8):2163-72. PMC: 3390707. DOI: 10.1007/s00125-012-2555-8. View

Sharma A, Deeb A, Iannuzzi J, Rickles A, Monson J, Fleming F . Tobacco smoking and postoperative outcomes after colorectal surgery. Ann Surg. 2012; 258(2):296-300. DOI: 10.1097/SLA.0b013e3182708cc5. View

Ordonez-Mena J, Walter V, Schottker B, Jenab M, ODoherty M, Kee F . Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium. Ann Oncol. 2017; 29(2):472-483. PMC: 6075220. DOI: 10.1093/annonc/mdx761. View

Huang Y, Lin J, Chen W, Lin T, Yang S, Jiang J . Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol. 2010; 137(2):211-20. DOI: 10.1007/s00432-010-0879-7. View

Lee C, Murphy D, McMahon C, Nolan B, Cullen G, Mulcahy H . Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy. J Gastrointest Cancer. 2015; 46(3):243-50. DOI: 10.1007/s12029-015-9709-0. View

MOERTEL C, Fleming T, Macdonald J, Haller D, Laurie J, Goodman P . Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990; 322(6):352-8. DOI: 10.1056/NEJM199002083220602. View

Clark T, Altman D, De Stavola B . Quantification of the completeness of follow-up. Lancet. 2002; 359(9314):1309-10. DOI: 10.1016/s0140-6736(02)08272-7. View

Shonka N, Anderson J, Panwalkar A, Reed E, Steen P, Ganti A . Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol. 2007; 23(4):515-9. DOI: 10.1385/MO:23:4:515. View

10.

Daniel C, Shu X, Ye Y, Gu J, Raju G, Kopetz S . Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre. Br J Cancer. 2015; 114(1):103-9. PMC: 4716542. DOI: 10.1038/bjc.2015.424. View

11.

Chang S, Beason T, Hunleth J, Colditz G . A systematic review of body fat distribution and mortality in older people. Maturitas. 2012; 72(3):175-91. PMC: 3367099. DOI: 10.1016/j.maturitas.2012.04.004. View

12.

Chubak J, Yu O, Ziebell R, Aiello Bowles E, Sterrett A, Fujii M . Risk of colon cancer recurrence in relation to diabetes. Cancer Causes Control. 2018; 29(11):1093-1103. PMC: 6230488. DOI: 10.1007/s10552-018-1083-3. View

13.

Phipps A, Shi Q, Newcomb P, Nelson G, Sargent D, Alberts S . Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147. J Clin Oncol. 2013; 31(16):2016-23. PMC: 3661936. DOI: 10.1200/JCO.2012.46.2457. View

14.

Liang P, Chen T, Giovannucci E . Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2009; 124(10):2406-15. DOI: 10.1002/ijc.24191. View

15.

Gerards M, van der Velden D, Baars J, Brandjes D, Hoekstra J, Vriesendorp T . Impact of hyperglycemia on the efficacy of chemotherapy-A systematic review of preclinical studies. Crit Rev Oncol Hematol. 2017; 113:235-241. DOI: 10.1016/j.critrevonc.2017.03.007. View

16.

Wei P, Kuo L, Huang M, Ting W, Ho Y, Wang W . Nicotine enhances colon cancer cell migration by induction of fibronectin. Ann Surg Oncol. 2011; 18(6):1782-90. DOI: 10.1245/s10434-010-1504-3. View

17.

Dinicola S, Morini V, Coluccia P, Proietti S, Danselmi F, Pasqualato A . Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs. Toxicol In Vitro. 2013; 27(8):2256-63. DOI: 10.1016/j.tiv.2013.09.020. View

18.

Meyerhardt J, Catalano P, Haller D, Mayer R, Macdonald J, Benson 3rd A . Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003; 21(3):433-40. DOI: 10.1200/JCO.2003.07.125. View

19.

OByrne K, Dalgleish A, Browning M, Steward W, Harris A . The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer. 2000; 36(2):151-69. DOI: 10.1016/s0959-8049(99)00241-5. View

20.

McCleary N, Niedzwiecki D, Hollis D, Saltz L, Schaefer P, Whittom R . Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803. Cancer. 2010; 116(4):957-66. PMC: 2884300. DOI: 10.1002/cncr.24866. View